Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USFDA approves new use of transplant drug based on real-world evidence
Marks first immunosuppressant drug approved to prevent rejection in adults and paediatric patients who receive lung transplants
Delta variant infected even vaccinated people during second wave of COVID-19: ICMR
Delta COVID variant infected more than 80 per cent people in India during the devastating second wave of the pandemic, affecting…
UCL finds over 200 symptoms of long COVID-19
Of the diverse range of symptoms, others included: visual hallucinations, tremors, itchy skin, changes to the menstrual cycle,…
PM interacts with CMs of six states to discuss COVID situation
The trend of increase in cases in Maharashtra and Kerala is a cause of concern, said Prime Minister Narendra Modi
BPaL treatment remains effective against tuberculosis, shows TB Alliance’s Zenix trial
The results from the trial were announced ahead of an oral abstract presentation next week at the 11th IAS Conference on HIV…
- Advertisement -
Venus Remedies launches R3SET to enter consumer healthcare business
The company's consumer healthcare division will come up with a wide range of products covering the crucial pain management,…
Second wave not yet over, Delta plus may not be dangerous: NTAGI chief
Dr N K Arora contended that the Delta Plus variant is "not going to be that disturbing or harmful" while the Delta variant…
Health ministry reviews preparations under “India COVID-19 Emergency Response and Health Systems…
Stresses on effective advance preparations for ensuring robust health infrastructure and efficient clinical management of COVID
Delta variant likely to become dominant COVID strain globally: WHO
Afghanistan, Nigeria and Ecuador are among the 15 countries that reported their first cases of the highly infectious variant in…
COVID-19 and thrombosis: Separating facts from fiction
With an extraordinary burden of thrombosis being observed among COVID-19 patients, Professor Roopen Arya, India spokesperson,…